J.P. Morgan Private Wealth Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-30,442
| Closed | -$154K | – | 1528 |
|
|
2019
Q3 | $154K | Buy |
30,442
+2,228
| +8% | +$11.3K | ﹤0.01% | 1369 |
|
|
2019
Q2 | $174K | Sell |
28,214
-490
| -2% | -$3.02K | ﹤0.01% | 1308 |
|
|
2019
Q1 | $133K | Buy |
28,704
+694
| +2% | +$3.22K | ﹤0.01% | 1399 |
|
|
2018
Q4 | $118K | Sell |
28,010
-758
| -3% | -$3.19K | ﹤0.01% | 1383 |
|
|
2018
Q3 | $180K | Buy |
28,768
+1,831
| +7% | +$11.5K | ﹤0.01% | 1489 |
|
|
2018
Q2 | $217K | Buy |
26,937
+4,652
| +21% | +$37.5K | ﹤0.01% | 1337 |
|
|
2018
Q1 | $166K | Buy |
22,285
+483
| +2% | +$3.6K | ﹤0.01% | 1197 |
|
|
2017
Q4 | $130K | Buy |
21,802
+2,525
| +13% | +$15.1K | ﹤0.01% | 1219 |
|
|
2017
Q3 | $142K | Buy |
19,277
+3,678
| +24% | +$27.1K | ﹤0.01% | 1182 |
|
|
2017
Q2 | $106K | Buy |
15,599
+1,027
| +7% | +$6.98K | ﹤0.01% | 1184 |
|
|
2017
Q1 | $138K | Buy |
+14,572
| New | +$138K | ﹤0.01% | 1281 |
|